Vulvar Cancer
100
25
34
44
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.0%
6 terminated out of 100 trials
88.0%
+1.5% vs benchmark
13%
13 trials in Phase 3/4
18%
8 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (100)
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
DESTINY-PANTUMOUR04
Danish Vulva Cancer Recurrence Study
Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study
Cancer Loyalty Card Study 2 (CLOCS-2)
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Electrochemotherapy for Recurrent Vulvar Cancer
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
Image-Guided Gynecologic Brachytherapy
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer